| N03AX24 |
N03AX24 Cannabidiol |
| N03AX30 |
N03AX30 Beclamide |
| N04 |
N04 Anti-parkinson drugs |
| N04A |
N04A Anticholinergic agents |
| N04AA |
N04AA Tertiary amines |
| N04AA01 |
N04AA01 Trihexyphenidyl |
| N04AA02 |
N04AA02 Biperiden |
| N04AA03 |
N04AA03 Metixene |
| N04AA04 |
N04AA04 Procyclidine |
| N04AA05 |
N04AA05 Profenamine |
| N04AA08 |
N04AA08 Dexetimide |
| N04AA09 |
N04AA09 Phenglutarimide |
| N04AA10 |
N04AA10 Mazaticol |
| N04AA11 |
N04AA11 Bornaprine |
| N04AA12 |
N04AA12 Tropatepine |
| N04AB |
N04AB Ethers Chemically Close To Antihistamines |
| N04AB01 |
N04AB01 Etanautine |
| N04AB02 |
N04AB02 orphenadrine (chloride) |
| N04AC |
N04AC Ethers of tropine or tropine derivatives |
| N04AC01 |
N04AC01 benzatropine |
| N04AC30 |
N04AC30 etybenzatropine |
| N04B |
N04B Dopaminergic agents |
| N04BA |
N04BA Dopa and dopa derivatives |
| N04BA01 |
N04BA01 Levodopa |
| N04BA02 |
N04BA02 Levodopa and decarboxylase inhibitor |
| N04BA03 |
N04BA03 Levodopa, decarboxylase inhibitor and COMT inhibitor |
| N04BA04 |
N04BA04 melevodopa |
| N04BA05 |
N04BA05 melevodopa and decarboxylase inhibitor |
| N04BA06 |
N04BA06 etilevodopa and decarboxylase inhibitor |
| N04BB |
N04BB Adamantane derivatives |